Mark McClellan, MD, PhD, the Robert J. Margolis professor of business, medicine and health policy, and founding director of the Duke-Margolis Center for Health Policy at Duke University.
Dr. McClellan is a physician and an economist who has informed and improved a wide range of strategies and policy reforms to advance health care. Before coming to Duke, he served as senior fellow in economic studies at the Brookings Institution. Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services and former commission of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. Such as Medicare prescription drug benefits and the FDA’s Critical Path Initiative.
Dr. McClellan is the founding chair and current board member of the Reagan-Udall Foundation for the FDA and a member of the National Academy of Medicine (NAM), where he chairs the Leadership Council and Science-Driven Health Care, co-chairs the guiding committee of the Health Care Payment Learning and Action Network and is a research associate of the National Bureau of Economic Research. He is also a senior advisor on the faculty of the University of Texas Dell Medical School, co-chair of the Accountable Care Learning Collaborative and a member of the Healthtech 4 Medicaid Board of Directors. Dr. McClellan is also an independent director on the boards of Johnson & Johnson, Cigna, Alignment Healthcare and Seer. He was previously an associate professor of economics and medicine with tenure at Stanford University and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.
Dr. McClellan earned his Bachelor of Arts from the University of Texas, MPA from Harvard University, MD from Harvard Medical School and his PhD from Massachusetts Institute of Technology.
